540 related articles for article (PubMed ID: 7923547)
1. Hypoxia and drug resistance.
Teicher BA
Cancer Metastasis Rev; 1994 Jun; 13(2):139-68. PubMed ID: 7923547
[TBL] [Abstract][Full Text] [Related]
2. In vitro testing of chemosensitivity in physiological hypoxia.
Grigoryan R; Keshelava N; Anderson C; Reynolds CP
Methods Mol Med; 2005; 110():87-100. PubMed ID: 15901930
[TBL] [Abstract][Full Text] [Related]
3. The Antiproliferative and Colony-suppressive Activities of STAT3 Inhibitors in Human Cancer Cells Is Compromised Under Hypoxic Conditions.
Tian J; Xiao H; Wu R; Cao Y; Li C; Xu R; Pierson CR; Finlay JL; Yang F; Gu N; Lin J
Anticancer Res; 2017 Feb; 37(2):547-553. PubMed ID: 28179300
[TBL] [Abstract][Full Text] [Related]
4. Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs.
Phillips RM
Cancer Chemother Pharmacol; 2016 Mar; 77(3):441-57. PubMed ID: 26811177
[TBL] [Abstract][Full Text] [Related]
5. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.
Brown JM
Br J Cancer; 1993 Jun; 67(6):1163-70. PubMed ID: 8512801
[TBL] [Abstract][Full Text] [Related]
6. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
[TBL] [Abstract][Full Text] [Related]
7. Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies.
Magagnin MG; Koritzinsky M; Wouters BG
Drug Resist Updat; 2006; 9(4-5):185-97. PubMed ID: 16926105
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
Li W; Sun X
Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
Frederiksen LJ; Sullivan R; Maxwell LR; Macdonald-Goodfellow SK; Adams MA; Bennett BM; Siemens DR; Graham CH
Clin Cancer Res; 2007 Apr; 13(7):2199-206. PubMed ID: 17404104
[TBL] [Abstract][Full Text] [Related]
10. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
Martínez-Sánchez G; Giuliani A
J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic regulation of metabolism offers new opportunities for anticancer therapy.
Denko NC
Expert Rev Anticancer Ther; 2014 Sep; 14(9):979-81. PubMed ID: 24930453
[TBL] [Abstract][Full Text] [Related]
12. Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia.
Emmenegger U; Morton GC; Francia G; Shaked Y; Franco M; Weinerman A; Man S; Kerbel RS
Cancer Res; 2006 Feb; 66(3):1664-74. PubMed ID: 16452226
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-activated prodrugs in cancer therapy: progress to the clinic.
Denny WA
Future Oncol; 2010 Mar; 6(3):419-28. PubMed ID: 20222798
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
Weinmann M; Welz S; Bamberg M
Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
[TBL] [Abstract][Full Text] [Related]
15. Tumor hypoxia in cancer therapy.
Brown JM
Methods Enzymol; 2007; 435():297-321. PubMed ID: 17998060
[TBL] [Abstract][Full Text] [Related]
16. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
17. Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia.
Teicher BA
Hematol Oncol Clin North Am; 1995 Apr; 9(2):475-506. PubMed ID: 7642474
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.
Evans SM; Jenkins WT; Shapiro M; Koch CJ
Adv Exp Med Biol; 1997; 411():215-25. PubMed ID: 9269430
[TBL] [Abstract][Full Text] [Related]
19. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
[TBL] [Abstract][Full Text] [Related]
20. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.
Teicher BA; Lazo JS; Sartorelli AC
Cancer Res; 1981 Jan; 41(1):73-81. PubMed ID: 7448778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]